Study to Assess the Change in Disease State When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Taiwan
Clinical trial NCT04818385 · COMPLETED
Trial details
- NCT number
- NCT04818385
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-31
- Primary completion
- 2025-08-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.